Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Giuseppe Cancello"'
Autor:
Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, Vincenzo Bagnardi, Eleonora Pagan, Emilia Montagna, Giuseppe Cancello, Raffaella Ghisini, Claudia Sangalli, Mara Negri, Manuelita Mazza, Monica Iorfida, Anna Cardillo, Angela Sciandivasci, Nadia Bianco, Ana Paula De Maio, Monica Milano, Giuseppe Maria Campennì, Loredana Sansonno, Giuseppe Viale, Anna Morra, Maria Cristina Leonardi, Viviana Galimberti, Paolo Veronesi, Marco Colleoni
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5167-5178 (2021)
Background: Adjuvant chemotherapy for Luminal B-like breast cancers usually includes anthracycline-based regimens. However, some patients are reluctant to receive chemotherapy because of side-effects, especially alopecia, and ask for a “less intens
Externí odkaz:
https://doaj.org/article/01c8698cc532419a944449afa4337d24
Autor:
Emilia Montagna, Giuseppe Cancello, Eleonora Pagan, Vincenzo Bagnardi, Elisabetta Munzone, Silvia Dellapasqua, Giuseppe Viale, Giovanni Mazzarol, Paolo Veronesi, Viviana Galimberti, Giorgia Santomauro, Marco Colleoni
Publikováno v:
Breast, Vol 53, Iss , Pp 138-142 (2020)
Background: Triple negative breast cancer encompasses several biological entities with different outcomes and is a priority to identify which patients require more treatment to reduce the risk of recurrence and which patients need less treatment. Pat
Externí odkaz:
https://doaj.org/article/0ffe5f3db11e4874a981ef6874bbfb58
Publikováno v:
Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering ISBN: 9783031308543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e858c013917b483ccf6901002482128
https://doi.org/10.1007/978-3-031-30855-0_11
https://doi.org/10.1007/978-3-031-30855-0_11
Autor:
Eleonora Pagan, Silvia Dellapasqua, Monica Iorfida, Claudia Sangalli, Vincenzo Bagnardi, Emilia Montagna, Loredana Sansonno, N. Bianco, Mara Negri, Anna Cardillo, G.M. Campennì, Monica Milano, Manuelita Mazza, Angela Sciandivasci, Giuseppe Cancello, Ana Paula De Maio, Elisabetta Munzone
Publikováno v:
Cancer Research. 80:P2-14
Background Adjuvant chemotherapy regimens for ‘Luminal B’ disease usually include anthracycline-based regimens with or without taxanes. However, several patients are reluctant to receive chemotherapy because of toxic side-effects, especially alop
Autor:
Giuseppe Cancello, Giuseppe Viale, Emilia Montagna, Eleonora Pagan, Marina Elena Cazzaniga, Elisabetta Munzone, Giulia Peruzzotti, Emanuela Omodeo Salè, Claudia Sangalli, Paolo Veronesi, Marco Colleoni, Mara Negri, Vincenzo Bagnardi, D Malengo
Publikováno v:
Anti-cancer drugs. 33(1)
Objective Metronomic chemotherapy is a treatment option for metastatic breast cancer (MBC) patients who require prolonged disease control without cumulative toxicity. Data available on the efficacy and tolerability of prolonged usage of metronomic th
Autor:
Sara Gandini, Silvia Dellapasqua, E Omodeo Salè, Giulia Viale, Elisabetta Munzone, P. Trillo Aliaga, D Malengo, Giuseppe Cancello, Monica Iorfida, Roberto Orecchia, Paolo Veronesi, Mario Rietjens, Federica Bellerba, M.C. Leonardi, Claudia Sangalli, Fabrizio Mastrilli, Emilia Montagna, Viviana Galimberti, Marco Colleoni, Manuelita Mazza
Publikováno v:
European Journal of Surgical Oncology
Autor:
Emilia Montagna, Giuseppe Cancello, Eleonora Pagan, Elisabetta Munzone, Monica Iorfida, Silvia Dellapasqua, Vincenzo Bagnardi, Marco Colleoni, Manuelita Mazza
Publikováno v:
ESMO Open
Background Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and endocrine therapy (ET) deeply transformed the treatment landscape of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer. Rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036fb3c60425194ff689a28d4daee19c
http://hdl.handle.net/10281/338996
http://hdl.handle.net/10281/338996
Autor:
Paolo Veronesi, Giuseppe Viale, Eleonora Pagan, Giuseppe Cancello, Giovanni Mazzarol, Elisabetta Munzone, Emilia Montagna, Marco Colleoni, Giorgia Irene Santomauro, Silvia Dellapasqua, Viviana Galimberti, Vincenzo Bagnardi
Publikováno v:
Breast, Vol 53, Iss, Pp 138-142 (2020)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Background Triple negative breast cancer encompasses several biological entities with different outcomes and is a priority to identify which patients require more treatment to reduce the risk of recurrence and which patients need less treatment. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd19fde1be28f64482043c7af5fa1bc6
http://hdl.handle.net/10281/282373
http://hdl.handle.net/10281/282373
Autor:
Silvia Dellapasqua, Eleonora Pagan, Monica Iorfida, Marco Colleoni, Manuelita Mazza, Giuseppe Cancello, Vincenzo Bagnardi, Emilia Montagna, Elisabetta Munzone
Publikováno v:
Journal of Clinical Oncology. 39:1059-1059
1059 Background: CDK4/6 inhibitors combined with endocrine therapy (ET) deeply transformed the treatment landscape of HR+/HER2− advanced breast cancer. After progression with the combination, there are no established guidelines for an optimal seque
Autor:
Paolo Veronesi, Ketti Mazzocco, Eleonora Pagan, B. Scateni, Greta Pettini, G.M. Campennì, Viviana Galimberti, Giuseppe Cancello, Gabriella Pravettoni, Elisabetta Munzone, N. Bianco, Marco Colleoni, A.P. De Maio, Manuelita Mazza, Vincenzo Bagnardi, Emilia Montagna, Monica Iorfida, Claudia Sangalli, Silvia Dellapasqua
Publikováno v:
Annals of Oncology. 30:v75-v76
Background Hormonal therapy (HT) is generally proposed to all patients with endocrine receptor positive breast cancer to reduce the risk of recurrence and death. However, HT is associated with side effects. The aim of the present study was to determi